Jianfei Xu
Papers
2
Total Citations
26
H-Index
2
About
Jianfei Xu is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for gastric cancer treatment, particularly through robotic and laparoscopic approaches. Based at a high-volume center, Xu has made significant contributions to comparative effectiveness research in gastric cancer surgery, demonstrating how robotic total gastrectomy (RTG) can improve intraoperative performance and outcomes over traditional laparoscopic methods. Their landmark 2023 study, with 19 citations, provided robust propensity score-matched evidence from 969 patients, showing that RTG offers superior short- and long-term outcomes, including reduced complications and better oncologic clearance. Xu further refined surgical decision-making by integrating preoperative perigastric artery CTA imaging, as shown in their 7-citation study, enabling personalized surgical planning that optimizes lymph node dissection and reduces operative risks. This work has helped establish evidence-based protocols for choosing between robotic and laparoscopic approaches, directly impacting clinical practice in high-volume centers. Xu’s research is widely cited by surgeons and oncologists seeking to improve gastric cancer outcomes through technological innovation, and their findings continue to shape guidelines for minimally invasive gastrectomy worldwide.
Research Focus
Key Achievements
Top Papers
- 1
- 2